Crossmark

Empagliflozin ameliorates vascular calcification in diabetic mice through inhibiting Bhlhe40-dependent NLRP3 inflammasome activation

Published Online: 2024-01-03

Published Print: 2024-04

Authors

Li, Xiao-xue

Chen, Zheng-dong

Sun, Xue-jiao

Yang, Yi-qing

Jin, Hong

Liu, Nai-feng
License Information

Text and Data Mining valid from 2024-01-03

Version of Record valid from 2024-01-03
More Information

Article History

Received: 20 September 2023

Accepted: 14 December 2023

First Online: 3 January 2024

Competing interests

: The authors declare no competing interests.

Document is current